Premium
Challenges in psychopharmacology: a drug information centre perspective
Author(s) -
Schjøtt J.
Publication year - 2016
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.12354
Subject(s) - psychopharmacology , perspective (graphical) , drug , medicine , medline , psychology , psychiatry , computer science , political science , artificial intelligence , law
Summary What is known and objective Questions about psychotropic drugs are frequently submitted to drug information centres ( DIC s). Twenty years’ experience from Norwegian DIC s was used to identify particular challenges in responding to those questions. Comment Questions about psychopharmacological therapy are usually patient‐related and are often difficult to answer. Frequent questions about psychotropic drugs come from experienced senior physicians in disciplines like psychiatry, geriatrics, general practice and neurology. The physicians often ask about specific drug use in pregnancy or breastfeeding, drug combinations and interactions, drug switching and formulations, and drug‐withdrawal reactions. What is new and conclusion There is a lack of relevant information in drug monographs and guidelines to inform answers to the questions posed for the care of individual patients. There is a clear need for these topics to be highlighted in the pre‐ and postgraduate teaching of physicians. The issues highlighted are likely to be of international relevance based on our experience of the use of international sources of drug information.